After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Adma Biologics Inc is $4.81B. A total of 2.72 million shares were traded on the day, compared to an average of 2.74M shares.
In the most recent transaction, Grossman Adam S sold 21,000 shares of ADMA for 18.92 per share on Mar 19 ’25. After the transaction, the President and CEO now owns 2,061,850 company shares. In a previous transaction on Mar 19 ’25, Grossman Adam S bought 84,000 shares at 18.71 per share.
Among the insiders who sold shares, Tade Brad L. disposed of 15,000 shares on Nov 22 ’24 at a per-share price of $21.15. This resulted in the CFO and Treasurer holding 199,433 shares of ADMA after the transaction. In another insider transaction, Grossman Adam S sold 48,967 shares at $21.10 per share on Nov 22 ’24. Company shares held by the President and CEO now total 1,989,007.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ADMA has a high of $23.64 and a low of $5.89.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ADMA’s latest balance sheet shows that the firm has $51.09M in Cash & Short Term Investments as of fiscal 2021. There were $102.92M in debt and $30.38M in liabilities at the time. Its Book Value Per Share was $1.48, while its Total Shareholder’s Equity was $141.17M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ADMA is Buy with a score of 5.00.
